JMP Securities reiterates Evelo Biosciences Inc. [EVLO] rating to Outperform and sets new price target at $27
JMP Securities maintained its Evelo Biosciences Inc. [NASDAQ:EVLO] rating to the equivalent of Outperform but changed the price target to $27, in a research note dated December 30, 2020. That figure represents around a 139.57% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with JMP Securities’s analysts […]
Let’s glance at the details Why Evelo Biosciences, Inc. (EVLO) shares surged dramatically in the AH trading
After-hours trading on Friday, Evelo Biosciences, Inc. (Nasdaq: EVLO), the stock plunged -11/56% to $10.25. It’s not clear what happened that caused the share price to fall, and investors may want to take that as a warning sign. A clinical-stage biotechnology company creating new oral medications with systemic effects prioritizes EDP1908 as its lead clinical […]
